Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TNGX stock hub

Tango Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TNGXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TNGX

In the news

Latest news · TNGX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-37.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-22.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TNGX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001819133
Company name	Tango Therapeutics, Inc.
Country	United States
Country code	US
Cusip	87583X109
Employees	137
Employees Change	-18%
Employees Change Percent	-11.61
Enterprise value	$3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US87583X1090
Last refreshed	2026-05-10
Market cap	$3.3B
Market cap category	Mid-Cap
Price	$23.02
Price currency	USD
Rev Per Employee	455,357.66x
Sector	Healthcare
Sic	2834
Symbol	TNGX
Website	https://www.tangotx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.06%
EV/Sales	48.26x
FCF yield	-4.21%
P/B ratio	9.04x
P/S ratio	53.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-178.39%
EBITDA Margin	-174.74%
Gross margin	-111.86%
Gross Profit	$-69.8M
Net Income	$-101.6M
Net Income Growth Years	1%
Pretax Margin	-162.85%
Profit Margin	-162.85%
Profit Per Employee	$-741,562
ROA	-19.45
Roa5y	-17.38
ROCE	-29.52
ROE	-37.23
Roe5y	-40.42
ROIC	-22.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,905.85%
Cagr3y	88.6%
Cagr5y	16.32%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	48.29x
Revenue Growth Years	3x
Revenue Growth3 Y	35.89x
Revenue Growth5 Y	52.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.17
Assets	$398.7M
Cash	$343.1M
Current Assets	$353.8M
Current Liabilities	$21.7M
Debt	$33.6M
Debt Equity	$0.1
Equity	$346.2M
Liabilities	$52.5M
Long Term Assets	$44.9M
Long Term Liabilities	$30.8M
Net Cash	$309.6M
Net Cash By Market Cap	$9.32
Net Cash Growth	39.81%
Net Debt Equity	$-0.89
Tangible Book Value	$346.2M
Tangible Book Value Per Share	$2.55
WACC	10.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.32
Net Working Capital	$-8.3M
Quick ratio	15.83
Working Capital	$332.1M
Working Capital Turnover	$0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,901.74%
200-day SMA	11.84
3Y total return	571.14%
50-day SMA	20.59
50-day SMA vs 200-day SMA	50over200
5Y total return	112.95%
All Time High	28.41
All Time High Change	-18.97%
All Time High Date	2026-04-21
All Time Low	1.03
All Time Low Change	2,134.95%
All Time Low Date	2025-05-08
ATR	1.6
Beta	1.22
Beta1y	1.49
Beta2y	1.25
Ch YTD	159.8
High	23.91
High52	28.41
High52 Date	2026-04-21
High52ch	-18.97%
Low	22.92
Low52	1.03
Low52 Date	2025-05-08
Low52ch	2,134.95%
Ma50ch	11.81%
Premarket Change Percent	-0.34
Premarket Price	$23.4
Premarket Volume	1,183
Price vs 200-day SMA	94.47%
RSI	50.92
RSI Monthly	75.87
RSI Weekly	67.29
Sharpe ratio	3.22x
Sortino ratio	8.11
Total Return	-6.35%
Tr YTD	159.8
Tr1m	16.26%
Tr1w	9.72%
Tr3m	84.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	5
Analyst Price Target Top	$24.2
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.32
Earnings Revenue Estimate	578,090x
Earnings Revenue Estimate Growth	-89.28x
Operating Income	$-111.3M
Operating margin	-178.4
Price target	$21.78
Price Target Change	$-5.39
Price Target Change Top	$5.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	77,399,571%
Float Percent	53.66%
Shares Insiders	1.3%
Shares Institutions	77.28%
Shares Out	144,242,271
Shares Qo Q	11.72%
Shares Yo Y	6.35%
Short Float	52%
Short Ratio	12.82
Short Shares	27.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-166.4M
Average Volume	3,178,867.95x
Bv Per Share	2.55
CAPEX	$-1M
Ch1m	16.26
Ch1w	9.72
Ch1y	1,901.7
Ch3m	84.01
Ch3y	571.1
Ch5y	113
Ch6m	192.5
Change	-1.96%
Change From Open	-2.91
Close	23.48
Days Gap	0.98
Depreciation Amortization	2,281,000
Dollar Volume	34,793,602
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-111.3M
EBITDA	$-109M
EPS	$-0.87
F Score	3
FCF	$-139.9M
FCF EV Yield	-4.65x
FCF Per Share	$-0.97
Financing CF	222,500,000
Fiscal Year End	December
Founded	2,014
Income Tax	$4,000
Investing CF	-40,865,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	13.45
Ma150ch	71.19%
Ma20	24.43
Ma20ch	-5.76%
Net CF	42,749,000
Next Earnings Date	2026-05-22
Open	23.71
Optionable	Yes
Position In Range	10.1
Post Close	23.02
Postmarket Change Percent	0.35
Postmarket Price	$23.1
Ppne	42,492,000
Pre Close	23.48
Price Date	2026-05-08
Ptbv Ratio	9.59
Relative Volume	0.48x
Revenue	62,384,000x
SBC By Revenue	42.37x
Share Based Comp	26,430,000
Tax By Revenue	0.01x
Tr6m	192.5%
Us State	Massachusetts
Volume	1,511,451
Z Score	5.03

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TNGX pay a dividend?

Capital-return profile for this ticker.

Performance

TNGX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TNGX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.3%

Float: +53.7% of shares outstanding

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TNGX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.9

Neutral momentum band

Price vs 200-day MA

+94.5%

50/200-day relationship not available

Beta (5Y)

1.22

More volatile than the market

Sharpe ratio

3.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TNGX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TNGX stock rating?

Tango Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TNGX analysis?

The full report lives at /stocks/TNGX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TNGX?

The latest report frames TNGX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TNGX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.